Decorin inhibits the proliferation of HepG2 cells by elevating the expression of transforming growth factor‑β receptor II

Liu,Yanfeng; Wang,Xuesong; Wang,Zhaohui; Ju,Wenbo; Wang,Dawei

doi:10.3892/etm.2016.3572

Decorin inhibits the proliferation of HepG2 cells by elevating the expression of transforming growth factor‑β receptor II

Authors:
- Yanfeng Liu
- Xuesong Wang
- Zhaohui Wang
- Wenbo Ju
- Dawei Wang
View Affiliations

Affiliations: Department of Human Anatomy, College of Basic Medical Sciences, Beihua University, Jilin, Jilin 132013, P.R. China
Published online on: August 4, 2016 https://doi.org/10.3892/etm.2016.3572
Pages: 2191-2195

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effects of decorin (DCN) on the proliferation of human hepatoma HepG2 cells and the involvement of transforming growth factor‑β (TGF‑β) signaling pathway. A vector containing DCN was transfected into HepG2 cells with the use of Lipofectamine 2000. Cell proliferation was assessed with an MTT assay, and western blot analysis was used to detect the protein expression of TGF‑β receptor I (TGF‑βRI), phosphorylated TGF‑βRI, p15 and TGF‑βRII. In addition, small interfering RNA (siRNA) silencing was performed to knock down the target gene. The results indicated that, compared with the control group, cell proliferation was significantly decreased in HepG2 cells transfected with DCN. In addition, DCN transfection significantly increased the phosphorylation level of TGF‑βRI in HepG2 cells. The expression of the downstream factor p15 was also significantly elevated in the DCN‑transfected HepG2 cells. Furthermore, DCN transfection significantly elevated the expression level of TGF‑βRII in HepG2 cells. By contrast, the silencing of TGF‑βRII significantly decreased the phosphorylation of TGF‑βRI in DCN‑transfected HepG2 cells. In addition, TGF‑βRII silencing abolished the effects of DCN on the proliferation of HepG2 cells. In conclusion, DCN elevated the expression level of TGF‑βRII, increased the phosphorylation level of TGF‑βRI, enhanced the expression of p15, and finally inhibited the proliferation of HepG2 cells. These findings may contribute to the understanding of the role of DCN in the pathogenesis of hepatic carcinoma and assist in the disease treatment.

View Figures

View References

1	Goldoni S, Owens RT, McQuillan DJ, Shriver Z, Sasisekharan R, Birk DE, Campbell S and Iozzo RV: Biologically active decorin is a monomer in solution. J Biol Chem. 279:6606–6612. 2004. View Article : Google Scholar : PubMed/NCBI
2	Scott PG, Dodd CM, Bergmann EM, Sheehan JK and Bishop PN: Crystal structure of the biglycan dimer and evidence that dimerization is essential for folding and stability of class I small leucine-rich repeat proteoglycans. J Biol Chem. 281:13324–13332. 2006. View Article : Google Scholar : PubMed/NCBI
3	Kresse H and Schönherr E: Proteoglycans of the extracellular matrix and growth control. J Cell Physiol. 189:266–274. 2001. View Article : Google Scholar : PubMed/NCBI
4	Geng Y, McQuillan D and Roughley PJ: SLRP interaction can protect collagen fibrils from cleavage by collagenases. Matrix Biol. 25:484–491. 2006. View Article : Google Scholar : PubMed/NCBI
5	Rühland C, Schönherr E, Robenek H, Hansen U, Iozzo RV, Bruckner P and Seidler DG: The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis. FEBS J. 274:4246–4255. 2007. View Article : Google Scholar : PubMed/NCBI
6	Reed CC and Iozzo RV: The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J. 19:249–255. 2002. View Article : Google Scholar : PubMed/NCBI
7	Iozzo RV: Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue. Lab Invest. 73:157–160. 1995.PubMed/NCBI
8	Buraschi S, Neill T, Owens RT, Iniguez LA, Purkins G, Vadigepalli R, Evans B, Schaefer L, Peiper SC, Wang ZX and Iozzo RV: Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model. PLoS One. 7:e455592012. View Article : Google Scholar : PubMed/NCBI
9	Nyman MC, Sainio AO, Pennanen MM, Lund RJ, Vuorikoski S, Sundström JT and Järveläinen HT: Decorin in human colon cancer: Localization in vivo and effect on cancer cell behavior in vitro. J Histochem Cytochem. 63:710–720. 2015. View Article : Google Scholar : PubMed/NCBI
10	Santra M, Reed CC and Iozzo RV: Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping with but distinct from the EGF-binding epitope. J Biol Chem. 277:35671–35681. 2002. View Article : Google Scholar : PubMed/NCBI
11	Santra M, Eichstetter I and Iozzo RV: An anti-oncogenic role for decorin: Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem. 275:35153–35161. 2000. View Article : Google Scholar : PubMed/NCBI
12	Csordás G, Santra M, Reed CC, Eichstetter I, McQuillan DJ, Gross D, Nugent MA, Hajnóczky G and Iozzo RV: Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem. 275:32879–32887. 2000. View Article : Google Scholar : PubMed/NCBI
13	Schönherr E, Sunderkötter C, Iozzo RV and Schaefer L: Decorin, a novel player in the insulin-like growth factor system. J Biol Chem. 280:15767–15772. 2005. View Article : Google Scholar : PubMed/NCBI
14	Schaefer L, Tsalastra W, Babelova A, Baliova M, Minnerup J, Sorokin L, Gröne HJ, Reinhardt DP, Pfeilschifter J, Iozzo RV and Schaefer RM: Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-1 receptor and mammalian target of rapamycin. Am J Pathol. 170:301–315. 2007. View Article : Google Scholar : PubMed/NCBI
15	Schönherr E, Sunderkötter C, Schaefer L, Thanos S, Grässel S, Oldberg A, Iozzo RV, Young MF and Kresse H: Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res. 41:499–508. 2004. View Article : Google Scholar : PubMed/NCBI
16	Schönherr E, Levkau B, Schaefer L, Kresse H and Walsh K: Decorin affects endothelial cells by akt-dependent and -independent pathways. Ann NY Acad Sci. 973:149–152. 2002. View Article : Google Scholar : PubMed/NCBI
17	Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD and Okada Y: Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-beta 1 release. Biochem J. 322:809–814. 1997. View Article : Google Scholar : PubMed/NCBI
18	Brown S, Melrose J, Caterson B, Roughley P, Eisenstein SM and Roberts S: A comparative evaluation of the small leucine-rich proteoglycans of pathological human intervertebral discs. Eur Spine J. 21(Suppl 2): S154–S159. 2012. View Article : Google Scholar : PubMed/NCBI
19	BarcellosHoff MH: Latency and activation in the control of TGF-beta. J Mammary Gland Biol Neoplasia. 1:353–363. 1996. View Article : Google Scholar
20	Halper J: Proteoglycans and diseases of soft tissues. Adv Exp Med Biol. 802:49–58. 2014. View Article : Google Scholar : PubMed/NCBI
21	Park C, Kim WS, Choi Y, Kim H and Park K: Effects of transforming growth factor beta (TGF-beta) receptor on lung carcinogenesis. Lung Cancer. 38:143–147. 2002. View Article : Google Scholar : PubMed/NCBI
22	Saji H, Nakamura H, Awut I, Kawasaki N, Hagiwara M, Ogata A, Hosaka M, Saijo T, Kato Y and Kato H: Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues. Ann Thorac Cardiovasc Surg. 9:295–300. 2003.PubMed/NCBI
23	Paik SY, Park YN, Kim H and Park C: Expression of transforming growth factor-beta 1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules. Mod Pathol. 16:86–96. 2003. View Article : Google Scholar : PubMed/NCBI
24	Schönherr E, Broszat M, Brandan E, Bruckner P and Kresse H: Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Arch Biochem Biophys. 355:241–248. 1998. View Article : Google Scholar : PubMed/NCBI
25	Harper J: Proteoglycans and diseases of soft tissuesProgress in Heritable Soft Connective Tissue Diseases. Springer; Dordrecht: pp. 49–58. 2014
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^ΔΔ ^Ct method. Methods. 254:402–408. 2001. View Article : Google Scholar